PleoPharma pharmaceutical company homepage, management team, product offering, contact us.
Total raised: $36M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 21.10.2025 | Series B | $36M | - |
Mentions in press and media 3
| Date | Title | Description |
| 21.10.2025 | PleoPharma Closes $36M Series B Financing | PleoPharma, Inc., a Pheonixville, PA-based company focused on finding treatments for cannabis-related health issues, closed a $36M Series B financing round. The backers were not disclosed. Led by Ginger Constantine MD, co-founder and CEO, P... |
| 05.09.2024 | PLEOPHARMA, INC. REPORTS POSITIVE PHASE 2b CLINICAL TRIAL DATA FOR MITIGATION OF CANNABIS WITHDRAWAL: A POTENTIAL FIRST IN CLASS TREATMENT | Phase 2b Study for PP-01 Met Its Primary Endpoint End of Phase 2 Meeting with FDA Completed Phase 3 Preparations Underway PHOENIXVILLE, Pa., Sept. 5, 2024 /PRNewswire/ -- PleoPharma, Inc., a privately held company focused on cannabis relate... |
| - | PleoPharma | “Pharmaceutical | PleoPharma | United States” |